Powder: -20°C for 3 years | In solvent: -80°C for 1 year
17(S)-HDHA is a primary mono-oxygenation product of docosahexaenoic acid in human whole blood, human leukocytes, and mouse brain. 17(S)-HDHA serves as a precursor to 17(S)-resolvins and has intrinsic biological activity, such as the inhibition of TNF-α-induced interleukin-1β expression in human glioma cells and inhibition of TNF-α-induced leukocyte trafficking to the mouse air pouch.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 μg | 約 35 days | ¥ 40,500 |
50 μg | 約 35 days | ¥ 72,500 |
100 μg | 約 35 days | ¥ 133,500 |
250 μg | 約 35 days | ¥ 312,500 |
説明 | 17(S)-HDHA is a primary mono-oxygenation product of docosahexaenoic acid in human whole blood, human leukocytes, and mouse brain. 17(S)-HDHA serves as a precursor to 17(S)-resolvins and has intrinsic biological activity, such as the inhibition of TNF-α-induced interleukin-1β expression in human glioma cells and inhibition of TNF-α-induced leukocyte trafficking to the mouse air pouch. |
分子量 | 344.49 |
分子式 | C22H32O3 |
CAS No. | 92693-03-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: Miscible
Ethanol: Miscible
DMF: Miscible
PBS (pH 7.2): 0.8 mg/mL
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
17(S)-HDHA 92693-03-3 17(S)HDHA 17HDHA 17(S) HDHA Inhibitor inhibitor inhibit